Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

Soft Tissues: Elastofibroma

Written2003-11Roberta Vanni
Dip. Scienze e Tecnologie Biomediche, Sezione di Biologia e Genetica, Università di Cagliari, Cittadella Universitaria, 09142 Monserrato (CA), Italy

(Note : for Links provided by Atlas : click)


ICD-Topo C470-C476,C478-C479,C490-C496,C498-C499 CONNECTIVE & SOFT TISSUE
ICD-Morpho 8820/0 Elastofibroma
Atlas_Id 5173
Phylum Soft Tissues::Elastofibroma
WHO/OMS Classification Soft Tissues
Other namesElastofibroma dorsi
Note Elastofibroma is a rare, slow-growing benign lesion of unknown origin, typically arising from the connective tissue between the subscapular area and the chest wall in elderly persons. It was first reported by Jarvi and Saxen in 1959 and published in 1961.
CT of the lower thorax: a semilunar-shaped mass (M) of soft tissue density with foci of fatty attenuations abutting two left-side ribs. A smaller heterogeneous mass is seen at the same location on the right. From Rivka Zissin MD and Myra Shapiro-Feinberg MD. IMAJ 2001; 3: 780. Courtesy of the Editor.

Clinics and Pathology

Etiology The etiology of this lesion remains unclear. It seems likely that the pseudotumor mass is the product of abnormal elastogenesis rather than of degeneration of preformed fibers. It has been suggested that repeated trauma by mechanical friction of the scapula against the ribs may induce the tumorlike process, since there is an increased prevalence in persons having a history of hard manual labor. A family history of the lesion is reported in up to one-third of cases, suggesting that its origin may be influenced genetically.
Epidemiology Elastofibroma is a rare condition whose exact incidence is unknown. Using computerized tomography, an incidence of 2% has been reported in the elderly, but it is found in autopsies, with lesions 3 cm in diameter or smaller, in 11.2% of men and 24.4% of women. It is more common in women (93%, usually older than 55 years) than men, whereas cases in young adults, teenagers and children have not been reported.
Clinics In 99% of reported cases, elastofibroma appears in the periscapsular area as a well-circumscribed large mass, most often not adhering to overlying skin. It is usually located in the lower subscapular area, deep in the rhomboid and latissimus dorsi muscles, firmly attached to the chest wall. Other, but very uncommon, locations include the deltoid muscle, ischial tuberosity, greater trochanter, olecranon, thoracic wall, foot, stomach, mediastinum, orbita and cornea. It is slow-growing. 10% of cases show bilateral lesions. Most patients are asymptomatic; hence the lesion can be overlooked. Elastofibroma has a distinctive appearance in ultrasonography, computed tomography and magnetic resonance imaging. Its MR and CT features are different from those of most other soft-tissue tumors, reflecting entrapped fat within a predominantly-fibrous mass. Although not pathognomonic, the presence of these features in a subscapular lesion in an older patient suggests a diagnosis of elastofibroma. Nonetheless, a biopsy is mandatory to confirm clinical diagnosis, since the subscapular site may be the location of neoplasms such as lipomas and sarcoma, as well as of metastases, extra-abdominal fibromatosis and hemangioma.
A. H&E stain: paucicellular, hyalinized stroma containing large, coarse, pale eosinophilic collagen and elastic fibers.
B. Vehoeff's elastic stain showing numerous globular and fiber-like elastic materials. Courtesy of Dr. Margaret Grimes,
Pathology Macroscopically the lesion appears as a grey-white spherical mass 5-10 cm in diameter.On microscopic examination, it appears as a dermal unencapsulated tumorlike mass composed of eosinophilic collagen and elastic fibers, with scattered aggregates of fat cells. The elastic fibers have a degenerated, beaded appearance or are fragmented into small petaloid or serrated globules arranged in a linear pattern.
On ultrastructural examination, the elastic fibers appear as granular or fibrillary aggregations of electron-dense material surrounded by an amorphous matrix with scattered microfibrils.
Treatment Complete surgical excision is the treatment of choice in symptomatic patients. Recurrence after surgery is very rare. Spontaneous regression without treatment has been observed in exceptional cases.
Evolution Elastofibroma is a benign condition, and malignant transformation has not been described.


Note Very few lesions have been studied using chromosome banding.
The prominent cytogenetic feature of elastofibroma is remarkably high karyotypic instability, responsible for structural changes involving virtually all chromosomes. Changes are usually random, and when clonal they have always been observed in no more than two cells. The most frequently nonrandomly affected breakpoint is at the 1p32 band, but breakpoints at 1p36 and 3q21 have been recorded.
Cytogenetics Molecular One study performed using comparative genomic hybridization showed the presence of DNA imbalances in 33% of the examined cases, with DNA gains at Xq12-q22 being the most common.


Clonal chromosome aberrations secondary to chromosome instability in an elastofibroma.
Batstone P, Forsyth L, Goodlad J
Cancer genetics and cytogenetics. 2001 ; 128 (1) : 46-47.
PMID 11458949
Elastrofibroma dorsi of the chest wall.
Bui-Mansfield LT, Chew FS, Stanton CA
AJR. American journal of roentgenology. 2000 ; 175 (1) : page 244.
PMID 10882280
Sonographic detection of elastofibroma dorsi.
Dalal A, Miller TT, Kenan S
Journal of clinical ultrasound : JCU. 2003 ; 31 (7) : 375-378.
PMID 12923883
Elastofibroma--a degenerative pseudotumor.
Järvi OH, Saxén AE, Hopsu-Havu VK, Wartiovaara JJ, Vaissalo VT
Cancer. 1969 ; 23 (1) : 42-63.
PMID 4303173
Elastofibroma dorse.
Acta pathologica et microbiologica Scandinavica. Supplement. 1961 ; 51(Suppl 144) : 83-84.
PMID 13789598
Cytogenetic instability, predominantly involving chromosome 1, is characteristic of elastofibroma.
McComb EN, Feely MG, Neff JR, Johansson SL, Nelson M, Bridge JA
Cancer genetics and cytogenetics. 2001 ; 126 (1) : 68-72.
PMID 11343783
Elastofibroma dorsi: elaboration of cytologic features and review of its pathogenesis.
Mojica WD, Kuntzman T
Diagnostic cytopathology. 2000 ; 23 (6) : 393-396.
PMID 11074644
Elastofibroma in Okinawa. A clinicopathologic study of 170 cases.
Nagamine N, Nohara Y, Ito E
Cancer. 1982 ; 50 (9) : 1794-1805.
PMID 7116305
Gain of Xq detected by comparative genomic hybridization in elastofibroma.
Nishio JN, Iwasaki H, Ohjimi Y, Ishiguro M, Koga T, Isayama T, Naito M, Kikuchi M
International journal of molecular medicine. 2002 ; 10 (3) : 277-280.
PMID 12165800
Elastofibroma: a familial occurrence.
Schepel JA, Wille J, Seldenrijk CA, van Ramshorst B
The European journal of surgery = Acta chirurgica. 1998 ; 164 (7) : 557-558.
PMID 9696981
Chromosome instability in elastofibroma.
Vanni R, Marras S, Faa G, Uccheddu A, Dal Cin P, Sciot R, Samson I, Van den Berghe H
Cancer genetics and cytogenetics. 1999 ; 111 (2) : 182-183.
PMID 10347562
Benign fibrous tissue tumors.
Weiss SW, Goldblum JR
Elastofibroma dorsi: CT appearance.
Zissin R, Shapiro-Feinberg M
The Israel Medical Association journal : IMAJ. 2001 ; 3 (10) : page 780.
PMID 11692559


This paper should be referenced as such :
Vanni, R
Soft tissue tumors: Elastofibroma
Atlas Genet Cytogenet Oncol Haematol. 2004;8(1):43-45.
Free journal version : [ pdf ]   [ DOI ]
On line version :

External links

arrayMap Topo ( C47,C49) arrayMap ((UZH-SIB Zurich)   [auto + random 100 samples .. if exist ]   [tabulated segments]
Disease databaseSoft Tissues: Elastofibroma
REVIEW articlesautomatic search in PubMed
Last year articlesautomatic search in PubMed

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Mon Dec 14 18:30:23 CET 2020

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us